{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:56:01Z","timestamp":1761562561783},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Uncertainty remains regarding the exact prognostic impact of biomarker elevation following percutaneous coronary intervention in patients with stable angina pectoris and the subsequent risk of death. We sought, therefore, to evaluate the effect of periprocedural myocardial infarction on the subsequent mortality risk following percutaneous coronary intervention in patients with stable angina pectoris and normal preprocedural cardiac biomarkers level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>After a systematic literature search was done in PubMed and EMBASE, we performed a meta-analysis of studies with post-procedural cardiac biomarkers data. All-cause mortality and cardiac death were evaluated in subjects with stable angina pectoris who underwent an elective coronary intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen studies with 24\u2009666 patients were included. The mean age was 64.2 years \u00b1 9.8 with about 3-quarters (74.9%) of these patients being men. The mean duration of follow-up was 18.1 months \u00b1 14.3. Periprocedural myocardial infarction, based on study-specific biomarker criteria, occurred in 14.3% of the patients. Periprocedural myocardial infarction conferred a statistically significant increase in the risk of all-cause mortality (odds ratio, 1.62; 95% confidence interval, 1.30\u20132.01;<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.0001; I<jats:sup>2<\/jats:sup>= 0%); where reported separately, cardiac death was also significantly increase (odds ratio, 2.77; 95% confidence interval, 1.60\u20134.80;<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.0003; I<jats:sup>2<\/jats:sup>= 0%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The occurrence of periprocedural myocardial infarction after an elective percutaneous coronary intervention in patients with stable angina pectoris is associated with a statistically significant increase in subsequent all-cause mortality and cardiac mortality.<\/jats:p><\/jats:sec>","DOI":"10.1097\/mca.0000000000000795","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T15:43:10Z","timestamp":1571067790000},"page":"137-146","source":"Crossref","is-referenced-by-count":7,"title":["Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24\u2009666 patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Mohamad","family":"Soud","sequence":"first","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hideo-Kajita","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Ho","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Yacob","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fares","family":"Alahdab","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"King","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne P.","family":"McFadden","sequence":"additional","affiliation":[{"name":"Interventional Cardiology, Cork University Hospital, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology.","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCINTERVENTIONS.108.765610","article-title":"Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.","volume":"1","author":"Prasad","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","article-title":"Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) study.","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.CIR.0000028146.71416.2E","article-title":"Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.","volume":"106","author":"Ellis","year":"2002","journal-title":"Circulation"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-analysis of the impact of strut thickness on outcomes in patients with drug-eluting stents in a coronary artery.","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am J Cardiol"},{"key":"R6-20230924","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcin.2009.09.002","article-title":"Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.","volume":"2","author":"Lindsey","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0735-1097(99)00298-3","article-title":"Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.","volume":"34","author":"Kini","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1258\/000456302760042155","article-title":"Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.","volume":"39","author":"Saadeddin","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/14017430801932824","article-title":"Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.","volume":"42","author":"Gravning","year":"2008","journal-title":"Scand Cardiovasc J"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0300-8932(09)71329-6","article-title":"Minor myocardial damage during percutaneous coronary intervention does not affect long-term prognosis.","volume":"62","author":"G\u00f3mez-Hospital","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"R11-20230924","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.amjcard.2008.10.044","article-title":"Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.","volume":"103","author":"De Labriolle","year":"2009","journal-title":"Am J Cardiol"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCINTERVENTIONS.110.957712","article-title":"Prognostic value of isolated troponin I elevation after percutaneous coronary intervention.","volume":"3","author":"Cavallini","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"R13-20230924","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2169\/internalmedicine.51.6732","article-title":"Deep echo attenuation without calcification increases the risk of periprocedural myonecrosis after elective percutaneous coronary intervention in patients with coronary artery disease.","volume":"51","author":"Mitsuba","year":"2012","journal-title":"Intern Med"},{"key":"R14-20230924","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV10I2A34","article-title":"Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the stent thrombosis in belgium (STIB) trial.","volume":"10","author":"Legrand","year":"2014","journal-title":"Eurointervention"},{"key":"R15-20230924","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ccd.26286","article-title":"Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion.","volume":"87","author":"Jang","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"suppl 1","key":"R16-20230924","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ccd.26406","article-title":"Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: results from a prospective, single center PCI registry.","volume":"87","author":"Zhang","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"e006752","DOI":"10.1161\/CIRCINTERVENTIONS.118.006752","article-title":"Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions.","volume":"11","author":"Koskinas","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MCA.0000000000000651","article-title":"Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.","volume":"29","author":"Kang","year":"2018","journal-title":"Coron Artery Dis"},{"key":"R19-20230924","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting.","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur Heart J"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"Liberati","year":"2009","journal-title":"Plos Med"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.recesp.2016.02.023","article-title":"Prognostic value of high-sensitivity troponin T after percutaneous coronary intervention in patients with stable coronary artery disease.","volume":"69","author":"Ndrepepa","year":"2016","journal-title":"Revista espanola de cardiologia (English ed)"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology\/ American College of Cardiology Committee**A list of contributors to this ESC\/ACC Consensus Document is provided in Appendix B.","volume":"36","author":"Antman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R25-20230924","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hc0502.104278","article-title":"Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?.","volume":"105","author":"Akkerhuis","year":"2002","journal-title":"Circulation"},{"key":"R26-20230924","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0735-1097(98)00551-8","article-title":"Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary thrombosis-II.","volume":"33","author":"Tardiff","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R27-20230924","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the society for cardiovascular angiography and interventions (SCAI).","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R28-20230924","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R29-20230924","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0002-8703(85)90343-6","article-title":"Creatine kinase release after successful percutaneous transluminal coronary angioplasty.","volume":"109","author":"Oh","year":"1985","journal-title":"Am Heart J"},{"key":"R30-20230924","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/0735-1097(95)00091-H","article-title":"Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT).","volume":"25","author":"Harrington","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R31-20230924","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.CIR.94.7.1528","article-title":"Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.","volume":"94","author":"Abdelmeguid","year":"1996","journal-title":"Circulation"},{"key":"R32-20230924","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12872-016-0293-4","article-title":"Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.","volume":"16","author":"Christensen","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20230924","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehi760","article-title":"Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.","volume":"27","author":"Miller","year":"2006","journal-title":"Eur Heart J"},{"key":"R34-20230924","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.107.752428","article-title":"Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.","volume":"118","author":"Jeremias","year":"2008","journal-title":"Circulation"},{"key":"R35-20230924","doi-asserted-by":"crossref","first-page":"e003202","DOI":"10.1161\/CIRCINTERVENTIONS.115.003202","article-title":"Preprocedural high-sensitivity cardiac troponin T and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.","volume":"9","author":"Zanchin","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R36-20230924","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.jacc.2016.08.059","article-title":"High-sensitivity troponin T and mortality after elective percutaneous coronary intervention.","volume":"68","author":"Ndrepepa","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R37-20230924","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2018.06.034","article-title":"Definitions of peri-procedural myocardial infarction and the association with one-year mortality: insights from CHAMPION trials.","volume":"270","author":"Olivier","year":"2018","journal-title":"Int J Cardiol"},{"key":"R38-20230924","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCINTERVENTIONS.111.962233","article-title":"Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry.","volume":"4","author":"Lindsey","year":"2011","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:12:15Z","timestamp":1721866335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000795","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}